Supervisor, Molecular Lab (Wed-Sat: 2pm-12:30am)
Tempus AI
Summary
Must have:
Job description
What You’ll Do:
- Provide daily oversight of a cutting-edge molecular workflow to provide high-quality next-generation sequencing data with rapid turnaround times
- Monitor laboratory processes to ensure that acceptable levels of analytic performance are maintained, to include review of quality control, instrument and equipment maintenance, and other quality assurance activities
- Assure all remedial actions are taken whenever test systems deviate from the laboratory's established performance specifications
- Perform quality review for samples within the sequencing workflow from extraction to sequencing.
- Maintain CLIA/ CAP/ NYSDOH compliance
- Schedule training and competency assessments for personnel
- Mentor team of clinical molecular technologists and extraction technologists
- Maintain safety within the laboratory and ensure all safety protocols are followed.
- Utilize automation and robotics to standardize the discovery pipeline from sample acquisition to sequencing output
- Schedule training and onboarding for new hires
Qualifications:
Must have:
- One of the following educational requirements:
- MD + 1 year clinical lab experience
- PhD (physical, chemical, or biological science) + 1 years clinical lab experience
- MS (physical, chemical, or biological science) + 2 years pertinent clinical lab experience
- BS (physical, chemical, or biological science) + 4 years of pertinent clinical lab experience
- Excellent communication skills
- Ability to delegate tasks to others
- Thrives in a fast-paced environment
- Ability to work with others to plan and carry out scientific programs
- Self-driven and works well in an interdisciplinary team with minimal direction
- Strong desire to build products that will save lives and change the course of cancer
- Impeccable attention to detail
Highly Desirable:
- Experience with next-generation sequencing
- Experience supervising others
- Work in a CLIA/CAP high-complexity laboratory
- Experience with robotics and automated liquid handling systems
- Knowledge of LIMS platforms and various computer systems
Available Shift: Wed-Sat 2pm-12:30am
Requirements
- MD + 1 year clinical lab experience
- PhD (physical, chemical, or biological science) + 1 years clinical lab experience
- MS (physical, chemical, or biological science) + 2 years pertinent clinical lab experience
- BS (physical, chemical, or biological science) + 4 years of pertinent clinical lab experience
- Excellent communication skills
- Ability to delegate tasks to others
- Thrives in a fast-paced environment
- Ability to work with others to plan and carry out scientific programs
- Self-driven and works well in an interdisciplinary team with minimal direction
- Strong desire to build products that will save lives and change the course of cancer
- Impeccable attention to detail
- Experience with next-generation sequencing
- Experience supervising others
- Work in a CLIA/CAP high-complexity laboratory
- Experience with robotics and automated liquid handling systems
- Knowledge of LIMS platforms and various computer systems
Benefits
- Medical benefits
- Incentive compensation
- Restricted stock units
Company overview
Tempus AI, Inc. (NASDAQ: TEM) is a pioneering healthcare technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. The company was established after Lefkofsky's wife was diagnosed with breast cancer, driving his mission to revolutionize cancer care through technology and artificial intelligence. Tempus specializes in applying AI to advance precision medicine by collecting and analyzing vast amounts of molecular, clinical, and genomic data. The company operates across multiple therapeutic areas including oncology, cardiology, radiology, neurology, psychiatry, and dermatology. Tempus provides comprehensive diagnostic services including next-generation sequencing (NGS), PCR profiling, and molecular pathology testing. Its AI-powered platform enables physicians to make real-time, data-driven decisions for personalized patient care and targeted therapies. The company went public in June 2024 and has expanded globally with operations in multiple countries. Tempus continues to innovate at the intersection of healthcare and artificial intelligence, aiming to ensure patients receive the right treatments at the right time for improved health outcomes.